Loading clinical trials...

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT01197794

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

The study will assess the efficacy, safety and tolerability of AZD1981 compared to non-active compound in asthmatic patients.

Lead sponsor: AstraZeneca•19 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

AstraZeneca

Related studies

Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting

NCT06786767 · Asthma, Asthma Patients, and more

COMPLETEDPhase 1

A Single-Arm Phase Ic Clinical Study of XKH001 Injection in Patients With Allergic Asthma After Multiple Doses

NCT07070297 · Asthma Patients

COMPLETEDPhase 4

ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression

NCT06869382 · Asthma Patients

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 1.

NCT01224938 · Asthma Patients, Healthy Subjects

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 6, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment1,144

Start dateOct 2010

Last updatedNov 6, 2013

Condition

Asthma Patients

Locations shown

Research Site

Fullerton, California

Research Site

Los Angeles, California

Research Site

Mission Viejo, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 6, 2013Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions